Armata Pharmaceuticals (ARMP) Enterprise Value Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.58% |
| Dec 31, 2025 | 16.37% |
| Sep 30, 2025 | 16.46% |
| Jun 30, 2025 | 51.19% |
| Mar 31, 2025 | 36.85% |
| Dec 31, 2024 | 3.34% |
| Sep 30, 2024 | -12.38% |
| Jun 30, 2024 | -14.62% |
| Mar 31, 2024 | -19.02% |
| Dec 31, 2023 | -11.91% |
| Sep 30, 2023 | -14.68% |
| Jun 30, 2023 | 14.29% |
| Mar 31, 2023 | -1.22% |
| Dec 31, 2022 | -35.03% |
| Sep 30, 2022 | -42.94% |
| Jun 30, 2022 | -41.00% |
| Mar 31, 2022 | -96.02% |
| Dec 31, 2021 | -2.11% |
| Sep 30, 2021 | 3.39% |
| Jun 30, 2021 | -4.37% |
| Mar 31, 2021 | -39.87% |
| Dec 31, 2020 | -23.42% |
| Sep 30, 2020 | -27.16% |
| Jun 30, 2020 | -30.21% |
| Mar 31, 2020 | -122.36% |
| Dec 31, 2019 | -5.54% |
| Sep 30, 2019 | -29.87% |
| Jun 30, 2019 | -22.68% |
| Mar 31, 2019 | 0.06% |
| Dec 31, 2018 | -1.03% |
| Sep 30, 2018 | -4.50% |
| Jun 30, 2018 | -2.43% |
| Mar 31, 2018 | 20.97% |
| Dec 31, 2017 | 7.96% |
| Sep 30, 2017 | 7.58% |
| Jun 30, 2017 | 10.62% |
| Mar 31, 2017 | 48.83% |
| Dec 31, 2016 | 36.83% |
| Sep 30, 2016 | 6.54% |
| Jun 30, 2016 | 1.10% |